Clinical Trial Update: Revolade Tablets Specified Drug-use Survey

View source ↗

Summary

A clinical trial update indicates a Revolade (eltrombopag) tablet study for aplastic anemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Revolade (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Aplastic Anemia | Status: RECRUITING